Cargando…

AAV Gene Therapy for MPS1-associated Corneal Blindness

Although cord blood transplantation has significantly extended the lifespan of mucopolysaccharidosis type 1 (MPS1) patients, over 95% manifest cornea clouding with about 50% progressing to blindness. As corneal transplants are met with high rejection rates in MPS1 children, there remains no treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vance, Melisa, Llanga, Telmo, Bennett, Will, Woodard, Kenton, Murlidharan, Giridhar, Chungfat, Neil, Asokan, Aravind, Gilger, Brian, Kurtzberg, Joanne, Samulski, R. Jude, Hirsch, Matthew L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4761992/ https://www.ncbi.nlm.nih.gov/pubmed/26899286 http://dx.doi.org/10.1038/srep22131

Ejemplares similares

Ocular Tolerability and Immune Response to Corneal Intrastromal AAV-IDUA Gene Therapy in New Zealand White Rabbits
por: Song, Liujiang, et al.
Publicado: (2020)

Biology of adeno-associated viral vectors in the central nervous system
por: Murlidharan, Giridhar, et al.
Publicado: (2014)

Direct Interaction of Human Serum Proteins with AAV Virions to Enhance AAV Transduction: Immediate Impact on Clinical Applications
por: Wang, Mei, et al.
Publicado: (2016)

AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis
por: Crabtree, Elizabeth, et al.
Publicado: (2019)

Preclinical toxicity evaluation of AAV for pain: evidence from human AAV studies and from the pharmacology of analgesic drugs
por: Pleticha, Josef, et al.
Publicado: (2014)

CNS-restricted Transduction and CRISPR/Cas9-mediated Gene Deletion with an Engineered AAV Vector
por: Murlidharan, Giridhar, et al.
Publicado: (2016)

A Fixed-Depth Microneedle Enhances Reproducibility and Safety for Corneal Gene Therapy
por: Gilger, Brian C., et al.
Publicado: (2020)

AAV Recombineering with Single Strand Oligonucleotides
por: Hirsch, Matthew L., et al.
Publicado: (2009)

Adeno-Associated Virus (AAV) Versus Immune Response
por: Rabinowitz, Joseph, et al.
Publicado: (2019)

Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye
por: Gilger, Brian C., et al.
Publicado: (2022)

AAV vector-meditated expression of HLA-G reduces injury-induced corneal vascularization, immune cell infiltration, and fibrosis
por: Hirsch, Matthew L., et al.
Publicado: (2017)

Global CNS Gene Delivery and Evasion of Anti-AAV Neutralizing Antibodies by Intrathecal AAV Administration in Non-Human Primates
por: Gray, Steven J., et al.
Publicado: (2013)

Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and “in vivo” tracing with AAV vector serotype 6
por: Ferreira, Joäo R., et al.
Publicado: (2012)

Adeno-Associated Virus Mediated Gene Therapy for Corneal Diseases
por: Bastola, Prabhakar, et al.
Publicado: (2020)

Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes
por: Gilkes, J.A., et al.
Publicado: (2015)

Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion
por: Castle, Michael J., et al.
Publicado: (2018)

The Golgi Calcium ATPase Pump Plays an Essential Role in Adeno-associated Virus Trafficking and Transduction
por: Madigan, Victoria J., et al.
Publicado: (2020)

Chimeric Mice Engrafted With Canine Hepatocytes Exhibits Similar AAV Transduction Efficiency to Hemophilia B Dog
por: Shao, Wenwei, et al.
Publicado: (2022)

Thermostability and in vivo performance of AAV9 in a film matrix
por: Doan, Trang Nguyen Kieu, et al.
Publicado: (2022)

Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme
por: Elmore, Zachary C., et al.
Publicado: (2020)

Inhibition of experimental autoimmune uveitis by intravitreal AAV-Equine-IL10 gene therapy
por: Crabtree, Elizabeth, et al.
Publicado: (2022)

AAV Exploits Subcellular Stress Associated with Inflammation, Endoplasmic Reticulum Expansion, and Misfolded Proteins in Models of Cystic Fibrosis
por: Johnson, Jarrod S., et al.
Publicado: (2011)

Preclinical biodistribution, tropism, and efficacy of oligotropic AAV/Olig001 in a mouse model of congenital white matter disease
por: Francis, Jeremy S., et al.
Publicado: (2021)

Sub-2 Å Ewald curvature corrected structure of an AAV2 capsid variant
por: Tan, Yong Zi, et al.
Publicado: (2018)

Tissue-Dependent Expression and Translation of Circular RNAs with Recombinant AAV Vectors In Vivo
por: Meganck, Rita M., et al.
Publicado: (2018)

Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity
por: Pei, Xiaolei, et al.
Publicado: (2020)

Site-specific modifications to AAV8 capsid yields enhanced brain transduction in the neonatal MPS IIIB mouse
por: Gilkes, Janine A., et al.
Publicado: (2020)

An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs
por: Sun, Junjiang, et al.
Publicado: (2018)

Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization
por: Wang, Haibo, et al.
Publicado: (2016)

Application of Noggin-Coated Electrospun Scaffold in Corneal Wound Healing
por: Mahmood, Nasif, et al.
Publicado: (2023)

Mannitol-facilitated CNS entry of rAAV2 vector significantly delayed the neurological disease progression in MPS IIIB mice
por: McCarty, D M, et al.
Publicado: (2009)

Long-term Evaluation of AAV-CRISPR Genome Editing for Duchenne Muscular Dystrophy
por: Nelson, Christopher E., et al.
Publicado: (2019)

AAV Gene Augmentation of Truncated Complement Factor H Differentially Rescues Ocular Complement Dysregulation in a Mouse Model
por: Grigsby, Daniel, et al.
Publicado: (2023)

Differences in MPS I and MPS II Disease Manifestations
por: Hampe, Christiane S., et al.
Publicado: (2021)

Evaluation of an AAV9-mini-dystrophin gene therapy candidate in a rat model of Duchenne muscular dystrophy
por: Le Guiner, Caroline, et al.
Publicado: (2023)

Safety and biodistribution assessment of sc-rAAV2.5IL-1Ra administered via intra-articular injection in a mono-iodoacetate-induced osteoarthritis rat model
por: Wang, Gensheng, et al.
Publicado: (2016)

Transduction optimization of AAV vectors for human gene therapy of glaucoma and their reversed cell entry characteristics
por: Rodriguez-Estevez, Laura, et al.
Publicado: (2019)

Weaknesses of the MPS
por: Holzer, B
Publicado: (2009)

Targeting Root Cause by Systemic scAAV9-hIDS Gene Delivery: Functional Correction and Reversal of Severe MPS II in Mice
por: Fu, Haiyan, et al.
Publicado: (2018)

Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo
por: Gupta, Suneel, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fu6opgpu105ah3s7qcd2vqgf55